标普和纳斯达克内在价值 联系我们

Ampio Pharmaceuticals, Inc. AMPE OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
50/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Ampio Pharmaceuticals, Inc. (AMPE) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 47/100 其中 2/7 项标准通过。

SharesGrow 7-Criteria Score
50/100
SG Score
View full scorecard →
价值
N/A
No coverage
~
未來
40/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
健康
100/100
Debt-to-Equity & liquidity
→ Health
护城河
28/100
→ Income
成长
80/100
→ Income
收入
N/A
No coverage

估值概览 — AMPE

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$-10.66
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2014 $-227.72 $76.79K $-38.13M -49650.3%
2015 $-184.70 $1.16M $-32.01M -2754.7%
2016 $-106.91 $0.00 $-19.16M -
2017 $-238.41 $0.00 $-51.89M -
2018 $91.90 $0.00 $33.99M -
2019 $-18.32 $0.00 $-13.63M -
2020 $-27.00 $0.00 $-15.89M -
2021 $-18.59 $0.00 $-17.08M -
2022 $-11.24 $0.00 $-16.34M -
2023 $-10.66 $0.00 $-8.63M -
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言